Idelalisib+Obinutuzumab in Patients With Relapsed/Refractory Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Follicular Lymphoma
Related studies linked through entity extraction aliases.
Copanlisib and Nivolumab in Treating Patients With Richter's Transformation or Transformed Indolent Non-Hodgkin Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001)
- Status
- COMPLETED
- Phase
- PHASE1
Study to Assess Umbralisib Plus Ublituximab in Participants With Treatment Naïve Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Study of Safety and Efficacy of Betalutin and Rituximab in Patients With FL
- Status
- COMPLETED
- Phase
- PHASE1
Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory CD19-positive Lymphoma.
- Status
- UNKNOWN
- Phase
- PHASE1
R2 in the Treatment of Follicular Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Antitumor Activity Study of Loncastuximab Tesirine and Durvalumab in Diffuse Large B-Cell, Mantle Cell, or Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Treatment of Patients With Relapsed or Refractory CD19+ Lymphoid Disease With T Cells Expressing a Third-generation CAR
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Rituximab + Immunotherapy in Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Trial of Radiotherapy and Durvalumab in DLBCL and FL
- Status
- COMPLETED
- Phase
- PHASE1
Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Pilot Investigator-Initiated Study of Ribavirin in Indolent Follicular Lymphoma and Mantle Cell Lymphoma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory or Relapsed Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Study on the Role of FDG-PET in Patients With FL at Time of Relapse/Progression
- Status
- COMPLETED
- Phase
- N/A
BTK Inhibitor BGB-3111 in Chinese Participants With Diffuse Large B-Cell Lymphoma (Non-GCB) and Indolent Lymphoma (FL and MZL)
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma
- Status
- RECRUITING
- Phase
- N/A